|
1
|
Ge K, Xue A, Bai J and Wang S: Keshan
disease-an endemic cardiomyopathy in China. Virchows Arch A Pathol
Anat Histopathol. 401:1–15. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oster O, Prellwitz W, Kasper W and
Meinertz T: Congestive cardiomyopathy and the selenium content of
serum. Clin Chim Acta. 128:125–132. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Lorgeril M, Salen P, Accominotti M,
Cadau M, Steghens JP, Boucher F and de Leiris J: Dietary and blood
antioxidants in patients with chronic heart failure. Insights into
the potential importance of selenium in heart failure. Eur J Heart
Fail. 3:661–669. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arroyo M, Laguardia SP, Bhattacharya SP,
Nelson MD, Johnson PL, Carbone LD, et al: Micronutrients in
African-Americans with decompensated and compensated heart failure.
Transl Res. 148:301–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Witte KK, Nikitin NP, Parker AC, von
Haehling S, Volk HD, Anker SD, et al: The effect of micronutrient
supplementation on quality-of-life and left ventricular function in
elderly patients with chronic heart failure. Eur Heart J.
26:2238–2244. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Djuranovic S, Nahvi A and Green R: A
parsimonious model for gene regulation by miRNAs. Science.
331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Viader A, Chang LW, Fahrner T, Nagarajan R
and Milbrandt J: MicroRNAs modulate Schwann cell response to nerve
injury by reinforcing transcriptional silencing of
dedifferentiation-related genes. J Neurosci. 31:17358–17369. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roldo C, Missiaglia E, Hagan JP, Falconi
M, Capelli P, Bersani S, et al: MicroRNA expression abnormalities
in pancreatic endocrine and acinar tumors are associated with
distinctive pathologic features and clinical behavior. J Clin
Oncol. 24:4677–4684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao JJ, Hua YJ, Sun DG, Meng XX, Xiao HS
and Ma X: Genome-wide microRNA profiling in human fetal nervous
tissues by oligonucleotide microarray. Childs Nerv Syst.
22:1419–1425. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhanot P, Brink M, Samos CH, Hsieh JC,
Wang Y, Macke JP, et al: A new member of the frizzled family from
Drosophila functions as a Wingless receptor. Nature. 382:225–230.
1996. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tamai K, Semenov M, Kato Y, Spokony R, Liu
C, Katsuyama Y, et al: LDL-receptor-related proteins in Wnt signal
transduction. Nature. 407:530–535. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kishida S, Yamamoto H, Ikeda S, Kishida M,
Sakamoto I, Koyama S and Kikuchi A: Axin, a negative regulator of
the wnt signaling pathway, directly interacts with adenomatous
polyposis coli and regulates the stabilization of beta-catenin. J
Biol Chem. 273:10823–10826. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sakanaka C, Weiss JB and Williams LT:
Bridging of beta-catenin and glycogen synthase kinase-3beta by axin
and inhibition of beta-catenin-mediated transcription. Proc Natl
Acad Sci USA. 95:3020–3023. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Behrens J, Jerchow BA, Wurtele M, Grimm J,
Asbrand C, Wirtz R, et al: Functional interaction of an axin
homolog, conductin, with beta-catenin, APC, and GSK3beta. Science.
280:596–599. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cadigan KM: Wnt-beta-catenin signaling.
Curr Biol. 18:R943–R947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rao TP and Kuhl M: An updated overview on
Wnt signaling pathways: a prelude for more. Circ Res.
106:1798–1806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katoh M and Katoh M: Wnt signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dursun N, Taskin E, Yerer AM and Sahin L:
Selenium-mediated cardioprotection against adriamycin-induced
mitochondrial damage. Drug Chem Toxicol. 34:199–207. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gu L, Pandey V, Geenen DL, Chowdhury SA
and Piano MR: Cigarette smoke-induced left ventricular remodelling
is associated with activation of mitogen-activated protein kinases.
Eur J Heart Fail. 10:1057–1064. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma J, Qian J, Ge J, Zeng X, Sun A, Chang
S, et al: Changes in left ventricular ejection fraction and
coronary flow reserve after coronary microembolization. Arch Med
Sci. 8:63–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang K, Shui Q, Xia Z and Yu Z: Changes
in the gene and protein expression of K (ATP) channel subunits in
the hippocampus of rats subjected to picrotoxin-induced kindling.
Brain Res Mol Brain Res. 128:83–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang L, Yang M, Marks P, White LM, Hurtig
M, Mi QS, Divine G and Gibson G: Serum non-coding RNAs as
biomarkers for osteoarthritis progression after ACL injury.
Osteoarthritis Cartilage. 20:1631–1637. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo CJ, Pan Q, Li DG, Sun H and Liu BW:
miR-15b and miR-16 are implicated in activation of the rat hepatic
stellate cell: An essential role for apoptosis. J Hepatol.
50:766–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan H, Song L, Cai J, Huang Y, Wu J, Yuan
J, et al: Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway
and contributes to apoptosis resistance in glioma cells. PLoS One.
6:e199462011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen J: An original discovery: selenium
deficiency and Keshan disease (an endemic heart disease). Asia
Pacific J Clin Nutr. 21:320–326. 2012.
|
|
29
|
Xu GL: The effectiveness of sodium
Selenite on prevention of acute attacks ofKeshan diseases. Chin Med
J. 92:471–476. 1979.
|
|
30
|
Chen X, Yang G, Chen J, Chen X, Wen Z and
Ge K: Studies on the relationships of selenium and Keshan disease.
Biol Trace Elem Res. 2:91–107. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Q, Liu M, Hou J, Jiang C, Li S and Wang
T: The prevalence of Keshan disease in China. Int J Cardiol.
168:1121–1126. 2013. View Article : Google Scholar
|
|
32
|
Salonen JT, Alfthan G, Huttunen JK,
Pikkarainen J and Puska P: Association between cardiovascular death
and myocardial infarction and serum selenium in a matched-pair
longitudinal study. Lancet. 2:175–179. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lubos E, Sinning CR, Schnabel RB, Wild PS,
Zeller T, Rupprecht HJ, et al: Serum selenium and prognosis in
cardiovascular disease: results from the AtheroGene study.
Atherosclerosis. 209:271–277. 2010. View Article : Google Scholar :
|
|
34
|
Lymbury RS, Marino MJ and Perkins AV:
Effect of dietary selenium on the progression of heart failure in
the ageing spontaneously hypertensive rat. Mol Nutr Food Res.
54:1436–1444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Latronico MV and Condorelli G: MicroRNAs
and cardiac pathology. Nat Rev Cardiol. 6:419–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Porrello ER: microRNAs in cardiac
development and regeneration. Clin Sci (Lond). 125:151–166. 2013.
View Article : Google Scholar
|
|
37
|
Van Aelst LN and Heymans S: MicroRNAs as
biomarkers for ischemic heart disease. J Cardiovasc Transl Res.
6:458–470. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nabialek E, Wanha W, Kula D, Jadczyk T,
Krajewska M, Kowalowka A, et al: Circulating microRNAs (miR-423-5p,
miR-208a and miR-1) in acute myocardial infarction and stable
coronary heart disease. Minerva Cardioangiol. 61:627–637.
2013.PubMed/NCBI
|
|
39
|
Sayed D, Hong C, Chen IY, Lypowy J and
Abdellatif M: MicroRNAs play an essential role in the development
of cardiac hypertrophy. Circ Res. 100:416–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xing HJ, Li YJ, Ma QM, Wang AM, Wang JL,
Sun M, et al: Identification of microRNAs present in congenital
heart disease associated copy number variants. Eur Rev Med
Pharmacol Sci. 17:2114–2120. 2013.PubMed/NCBI
|
|
41
|
Melman YF, Shah R and Das S: MicroRNAs in
heart failure: is the picture becoming less miRky? Circ Heart Fail.
7:203–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Oliveira-Carvalho V, Da SM, Guimaraes GV,
Bacal F and Bocchi EA: MicroRNAs: new players in heart failure. Mol
Biol Rep. 40:2663–2670. 2013. View Article : Google Scholar
|
|
43
|
Kim GH: MicroRNA regulation of cardiac
conduction and arrhythmias. Transl Res. 161:381–392. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Madrigal-Matute J, Rotllan N, Aranda JF
and Fernández-Hernando C: MicroRNAs and atherosclerosis. Curr
Atheroscler Rep. 15:3222013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kontaraki JE, Marketou ME, Zacharis EA,
Parthenakis FI and Vardas PE: Differential expression of vascular
smooth muscle-modulating microRNAs in human peripheral blood
mononuclear cells: novel targets in essential hypertension. J Hum
Hypertens. 28:5410–516. 2014. View Article : Google Scholar
|
|
46
|
Gessert S and Kühl M: The multiple phases
and faces of wnt signaling during cardiac differentiation and
development. Circ Res. 107:186–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
van de Schans VA, Smits JF and
Blankesteijn WM: The Wnt/frizzled pathway in cardiovascular
development and disease: friend or foe? Eur J Pharmacol.
585:338–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Blankesteijn WM, van Gijn ME,
Essers-Janssen YP, Daemen MJ and Smits JF: Beta-catenin, an inducer
of uncontrolled cell proliferation and migration in malignancies,
is localized in the cytoplasm of vascular endothelium during
neovascularization after myocardial infarction. Am J Pathol.
157:877–883. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chilosi M, Poletti V, Zamò A, Lestani M,
Montagna L, Piccoli P, et al: Aberrant Wnt/beta-catenin pathway
activation in idiopathic pulmonary fibrosis. Am J Pathol.
162:1495–1502. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zelarayán LC, Noack C, Sekkali B, Kmecova
J, Gehrke C, Renger A, et al: Beta-Catenin downregulation
attenuates ischemic cardiac remodeling through enhanced resident
precursor cell differentiation. Proc Natl Acad Sci USA.
105:19762–19767. 2008. View Article : Google Scholar : PubMed/NCBI
|
